Pharma Journalist -

Altasciences is excited to announce the completion of their laboratory expansion. The additional space will be dedicated to ligand binding and cell-based assays. Altasciences’…
Read More...

With the event now just 1 week away, I wanted to remind you that there is still time to secure your place at SMi's 4th annual event, Lyophilization USA, taking place on November 15th…
Read More...

Glenmark Pharmaceuticals announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings…
Read More...

Samsung BioLogics, a global leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) based in South Korea, announced today that the asset transfer deal…
Read More...

Concept Life Sciences announced the expansion of its regulatory GLP (good laboratory practice) capabilities at the Group’s Dundee and Bradford sites. The MHRA has confirmed the…
Read More...

IRX Therapeutics announced that the company’s assets have been acquired by the newly formed Brooklyn ImmunoTherapeutics LLC. This name reflects the company’s focus on advancing the…
Read More...

AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma,…
Read More...

SMi’s Pharma is proud to announce the 3rd Annual 3D Cell Culture is back and the conference is taking place at the Copthorne Tara Hotel in London, UK on 20th and 21st February 2019.…
Read More...

Quotient Sciences has significantly expanded its formulation development and clinical trial manufacturing operations at its Reading, U.K., facility. The program’s investment has tripled…
Read More...

Bristol-Myers Squibb Company and Infinity Pharmaceuticals announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's Opdivo in combination with Infinity's IPI-549 in…
Read More...